Mounjaro leads to far more weight loss than Ozempic, real-world study finds
The Today Show via AOL· 2 days agoTirzepatide in Mounjaro is more effective for weight loss than semaglutide in Ozempic, analysis...
Zepbound: How Does the Latest FDA-Approved Weight Loss Injection Compare to Similar Drugs?
Health via Yahoo News· 3 days agoThe FDA recently approved Zepbound, a new injectable medication, to treat chronic weight management....
Weight Loss Drugs Aren't Usually Covered By Insurance—But That Could Change
Women's Health via Yahoo News· 2 days agoOzempic (with the active ingredient semaglutide) is a great example of this framework in action: The...
... Her Due To Her Use Of Ozempic A Week After Admitting She “Can’t Afford” To Lose Anymore Weight
BuzzFeed News via Yahoo News· 2 days agoDave Benett / Dave Benett / Getty Images For those who don’t know, Ozempic is a drug that has become...
Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?
Motley Fool· 8 hours agoElectronic health records say tirzepatide, the active ingredient in Mounjaro and Zepbound, is better...
“We got it wrong”: WeightWatchers CEO embraces “life saving” weight loss drugs
Salon via Yahoo News· 2 days agoImages WeightWatchers CEO Sima Sistani issued an apology on behalf of WeightWatchers, saying the...
Diabetes drug Mounjaro more effective for weight loss than Ozempic: Analysis
The Hill via Yahoo News· 3 days agoNew diabetes drug Mounjaro is more effective for weight loss that the popular drug Ozempic, an...
Weight-loss drug Is more powerful than Ozempic but it's also pricier
Newsweek· 1 day agoDespite being arguably lesser known on the market, an Ozempic competitor drug has proven to be up to...
FDA approves new version of Eli Lilly’s diabetes drug for weight loss
Miami Herald via Yahoo News· 4 days agoA new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S....
CONSUMERS USING GLP-1 MEDICATIONS FOR WEIGHT LOSS SKEW YOUNGER AND HIGHER INCOME, NUMERATOR REPORTS
Benzinga· 4 hours agoCHICAGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Numerator, a data and tech company serving the market research space, is reporting new information on the demographics of consumer households using GLP-1 medications. The